Clinical Trials Directory

Trials / Conditions / Advanced Endometrial Carcinoma

Advanced Endometrial Carcinoma

10 registered clinical trials studyying Advanced Endometrial Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Comb
NCT07198074
National Cancer Institute (NCI)Phase 3
RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957
NiKang Therapeutics, Inc.Phase 1
TerminatedA Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NCT06264921
NiKang Therapeutics, Inc.Phase 1
Active Not RecruitingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
NCT05691504
National Cancer Institute (NCI)Phase 1
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
RecruitingPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa
NCT05092373
M.D. Anderson Cancer CenterPhase 1
RecruitingIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or C
NCT04491942
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
Active Not RecruitingCabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial C
NCT03367741
National Cancer Institute (NCI)Phase 2